Clinical Trial: Evaluation of the Efficacy and Safety of Gelsectan in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome

U.S., June 3 -- ClinicalTrials.gov registry received information related to the study (NCT07000383) titled 'Evaluation of the Efficacy and Safety of Gelsectan in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome' on May 30.

Brief Summary: This clinical study aims to investigate the effectiveness and safety of Gelsectan, a treatment containing xyloglucan, in adults diagnosed with diarrhea-predominant irritable bowel syndrome (IBS-D) in Vietnam. IBS-D is a common digestive disorder that causes frequent diarrhea along with abdominal pain and bloating, significantly affecting patients' daily life and wellbeing.

The main goal of the study is to determine whether Gelsectan can reduce the severity of symptoms such as diarrhea, abdom...